(Q33697079)

28 July 2017

Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients (English)

1 reference

28 July 2017

1 reference

1 reference

T J Walsh

1

1 reference

28 July 2017

V Yeldandi

2

1 reference

28 July 2017

M McEvoy

3

1 reference

28 July 2017

C Gonzalez

4

1 reference

28 July 2017

S Chanock

5

1 reference

28 July 2017

A Freifeld

6

1 reference

28 July 2017

N I Seibel

7

1 reference

28 July 2017

P O Whitcomb

8

1 reference

28 July 2017

P Jarosinski

9

1 reference

28 July 2017

G Boswell

10

1 reference

28 July 2017

I Bekersky

11

1 reference

28 July 2017

A Alak

12

1 reference

28 July 2017

D Buell

13

1 reference

28 July 2017

J Barret

14

1 reference

28 July 2017

W Wilson

15

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 September 1998

1 reference

Antimicrobial Agents and Chemotherapy

28 July 2017

1 reference

28 July 2017

42

1 reference

28 July 2017

9

1 reference

28 July 2017

2391-2398

1 reference

Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105839

Lipid formulations of amphotericin B: recent progress and future directions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105839

Influence of lipoproteins on renal cytotoxicity and antifungal activity of amphotericin B.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105839

Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105839

Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105839

Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections. Evaluation of United Kingdom compassionate use data

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105839

Comparative capacity of four antifungal agents to stimulate murine macrophages to produce tumour necrosis factor alpha: an effect that is attenuated by pentoxifylline, liposomal vesicles, and dexamethasone

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105839

Therapeutic evaluation of free and liposome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105839

Amphotericin B: 30 years of clinical experience

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105839

Cardiopulmonary toxicity after liposomal amphotericin B infusion

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105839

Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105839

Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105839

Nosocomial pneumonia in patients having bone marrow transplant attributable mortality and risk factors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105839

Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105839

Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105839

Amphotericin B-phospholipid interactions responsible for reduced mammalian cell toxicity

30 October 2018

1 reference

12 December 2020

Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients

1 reference

12 December 2020

Pharmacokinetics of liposomal amphotericin B (AmBisome) versus other lipid-based formulations

1 reference

12 December 2020

Pulmonary toxicity during infusion of liposomal amphotericin B in two patients with acute leukemia

1 reference

12 December 2020

1 reference

12 December 2020

A high-performance liquid chromatographic assay for the determination of amphotericin B serum concentrations after the administration of AmBisome, a liposomal amphotericin B formulation

1 reference

12 December 2020

Distribution of doubly radiolabelled amphotericin B methyl ester and amphotericin B in the non-human primate, Macaca mulatta

1 reference

12 December 2020

Renal clearance of carprofen in the isolated perfused rat kidney

1 reference

12 December 2020

Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells

1 reference

12 December 2020

Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients

1 reference

12 December 2020

Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients

1 reference

12 December 2020

Identifiers

PMCID

105839

1 reference

28 July 2017

1 reference